OABI
OmniAb, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.33
−8.84%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.02x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -0.74x
- Net debt / EBITDA
- 0.21x
Liquidity & coverage
- Current ratio
- 4.80x
- Quick ratio
- 4.80x
- Cash ratio
- 3.78x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $52.3M
Cash & dividend
- FCF / debt
- -0.96x
- Cash flow / debt
- -0.93x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026